1. Disposition of orally administered ¹⁴C-prednimustine in cancer patients

   • Robert C. Gaver
   • George Deeb
   • Robert D. Smyth

   Original Articles Pages: 139 - 143

2. Mechanism of the antitumor activity of 5,5′-bis(2′-tetrahydropyranyl) secalonic acid D against Meth-A

   • Motomu Shimizu
   • Minako Nakamura
   • Takao Iwaguchi

   Original Articles Pages: 144 - 146

3. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system

   • Rainhardt Osieka
   • Peter Glatte
   • Carl Gottfried Schmidt

   Original Articles Pages: 147 - 152

4. A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL)

   • J. A. Child
   • D. L. Barnard
   • J. Thorogood

   Original Articles Pages: 153 - 158

5. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro

   • Philip Lazarus
   • Judith St Germina
   • Lawrence C. Panasci

   Original Articles Pages: 159 - 161

6. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia

   • Henry Gerad
   • Merrill J. Egorin
   • Joseph Aisner

   Original Articles Pages: 162 - 166

7. Effect of a single high dose and repeated small doses of dianhydrogalactitol (DAG; NSC-132313) on rat intestinal mucosa

   • Judit Kralovánszky
   • Noémi Prajda
   • Zoltán Szentirmay

   Original Articles Pages: 167 - 171

8. Pharmacokinetics of high-dose methotrexate in dogs

   • Peter Porpaczy
   • Christian P. Schmidbauer
   • Arno T. Endler

   Original Articles Pages: 172 - 176

9. In vitro interactions of TNO₆ with human plasma

   • Bernard Hecquet
   • Lucien Adenis
   • Alain Demaille

   Original Articles Pages: 177 - 181

10. Development and characterization of a new murine renal tumor model

    • M. Vandendris
    • P. Dumont
    • G. Atassi

    Original Articles Pages: 182 - 187

11. Serum profiles and safety of intermediate-dose (500–1,000 mg) methotrexate following IV and IM administration

    • Barry M. Colls
    • Richard A. Robson
    • Gavin W. Tisch

    Original Articles Pages: 188 - 190

12. CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma

    • Don V. Jackson Jr
    • Hyman B. Muss
    • H. Bradley Wells

    Original Articles Pages: 191 - 195

13. Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma

    • P. M. Wilkinson
    • P. A. O'Neill
    • S. B. Lucas

    Original Articles Pages: 196 - 199

14. The testis

    • Harold Jackson
    • Marison Bock
    • Mehroo Lendon

    Short Communication Pages: 200 - 202

15. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer

    • Geoffrey Falkson
    • H. L. Pretorius
    • H. S. Schoeman

    Short Communication Pages: 203 - 204

16. Optimum scheduling during combination chemotherapy of murine leukemia

    • F. M. Sirotnak
    • F. A. Schmid
    • J. A. Montgomery

    Short Communication Pages: 205 - 207